Dr. Eshelman has been the Founding Chairman of Furiex Pharmaceuticals, Inc., since 2009 and has been its Director since October 2009. He served as Chief Executive Officer of Pharmaceutical Product Development Inc. from July 1990 to July 2009.
Dr. Eshelman founded Pharmaceutical Product Development Inc.'s predecessor and served as the Chief Executive Officer until 1989. Dr. Eshelman served as the Senior Vice President, Development of Glaxo Inc and held various roles in drug development with other pharmaceutical companies.
Dr. Eshelman served as an Executive Chairman of Furiex Pharmaceutical Inc. He served as an Executive Chairman of Pharmaceutical Product Development since July 1, 2009.
He serves on a number of industry boards, including the Association of Clinical Research Organizations. He served as a Director of Spotlight Health, Inc. and Takeda California, Inc. Dr. Eshelman served as a Director of Glaxo Inc. from 1989 to 1990 and as a Director of Accelerator Corporation and Takeda San Diego, Inc. Dr. Eshelman serves on the Board of visitors for the School of Pharmacy at the University of North Carolina.
He has a Doctorate of Pharmacy from the University of Cincinnati and a Bachelor’s in Pharmacy from the University of North Carolina at Chapel Hillmore » « less